YUSEI (00096) appoints He Xiangli as an independent non-executive director.
YUSEI (00096) announces the appointment of Mr. He Xiangli as an independent non-executive director, the chairman of the Company's Audit Committee, and a member of the Company's Remuneration Committee and Nomination Committee, effective from February 1, 2026.
YUSEI (00096) announces the appointment of Mr. He Xiangli as an independent non-executive director, Chairman of the Company Audit Committee, and member of the Company Remuneration Committee and Nomination Committee, effective from February 1, 2026.
Related Articles
Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.
US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.
US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.
Oral weight loss drug Wegovy performs well, Novo Nordisk A/S Sponsored ADR Class B (NVO.US) stock price rebounds after two years of decline, up about 16% year-to-date.
US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.
US Stock Market Move | KLA Corporation (KLAC.US) tumbles 10% as its performance guidance for the third quarter of the 2026 fiscal year falls below expectations.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
